Welcome to LookChem.com Sign In|Join Free
  • or
2-Hexadecyl-malonic acid is a long-chain carboxylic acid that features both a malonic acid group and a hexadecyl group. 2-HEXADECYL-MALONIC ACID is known for its surfactant properties and ability to form micelles, which can be beneficial in various applications.
Used in Pharmaceutical Industry:
2-Hexadecyl-malonic acid is used as a solubility enhancer for poorly soluble compounds, due to its surfactant properties that can reduce surface tension and improve solubility.
Used in Cosmetic Industry:
2-Hexadecyl-malonic acid is used as a surfactant to stabilize formulations and improve the texture and feel of cosmetic products.
Used in Drug Delivery Systems:
2-Hexadecyl-malonic acid is used as a component in drug delivery systems, where its malonic acid group may contribute to enhancing the stability and bioavailability of certain drugs.

4371-64-6

Post Buying Request

4371-64-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4371-64-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4371-64-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,7 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4371-64:
(6*4)+(5*3)+(4*7)+(3*1)+(2*6)+(1*4)=86
86 % 10 = 6
So 4371-64-6 is a valid CAS Registry Number.
InChI:InChI=1/C19H36O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(18(20)21)19(22)23/h17H,2-16H2,1H3,(H,20,21)(H,22,23)

4371-64-6Relevant academic research and scientific papers

NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

-

, (2014/08/20)

This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses related thereto. In certain embodiments, the disclosure relates to halogenated nucleosides optionally conjugated to a phosphorus oxide or pharmaceutically acceptable salts thereof. In certain embodiments, the disclosure relates to conjugate compounds or pharmaceutically acceptable salts thereof comprising an amino acid ester or a sphingolipid or derivative linked by a phosphorus oxide to a nucleotide or nucleoside. In certain embodiments, the disclosure contemplates pharmaceutical compositions comprising these compounds for uses in treating infectious diseases, viral infections, and cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4371-64-6